When you need to develop a biomarker for clinical trial but can’t wait the 18 to 24 months it usually requires, Veridex CRS has the answer. We’ve perfected a process that enables us to build an assay in 3 to 6 months on average, depending on the complexity. And you can be confident our assays have the robustness you need to move into clinical trials.
We’ve built four critical milestones, or “go and no go” decision points, into our biomarker assay development process. Why? We want to make sure we’re always meeting your expectations. We also want to determine if your assay is feasible before you get too far down the road, so you don’t waste your precious resources or have to pay for a whole assay development. It’s that kind of flexibility that makes our service stand apart.
After we know your assay is feasible, we verify it to make sure it works and delivers the desired results. Next, it’s time to transfer it to our testing lab and train other scientists to use it. Finally, we validate the assay with real patient samples.
To learn more about our painstaking yet fast and efficient process, please see the graphic to the right.
This site is published by Veridex, LLC, which is solely responsible for its contents. © Veridex, LLC 2011. This site is intended for use by residents of the United States of America.
This information is intended for biotech, pharmaceutical, and/or academic researchers. The products/services discussed are for research use only and not for use in diagnostic
procedures. Last updated on: 22 April 2013